Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Financial Flexibility Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-43.91 Million (operating CF €-64.53 Million minus capex €20.62 Million) represents 0% of total liabilities (€3.97 Billion). Check how strategically is Tianjin Zhong Xin Pharmaceutical Group C's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 13 annual periods. See working capital to net assets of Tianjin Zhong Xin Pharmaceutical Group C to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year free cash flow to debt coverage for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For the full company profile including market capitalisation, see 2TZ market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €579.68 Million | €461.07 Million | €4.59 Billion | ▼ -64.6% |
| 2024 | 0.36x | €1.04 Billion | €924.67 Million | €2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | €829.42 Million | €688.49 Million | €3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | €785.15 Million | €677.25 Million | €3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | €1.01 Billion | €852.40 Million | €2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | €860.58 Million | €671.42 Million | €2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | €701.10 Million | €495.49 Million | €2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | €525.95 Million | €350.14 Million | €2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | €110.45 Million | €-3.97 Million | €2.00 Billion | ▼ -78.7% |
| 2016 | 0.26x | €533.98 Million | €417.77 Million | €2.06 Billion | ▲ +12.4% |
| 2015 | 0.23x | €453.22 Million | €360.58 Million | €1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | €357.01 Million | €286.85 Million | €2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | €285.86 Million | €213.44 Million | €2.69 Billion | — |